IL13RA2 and glioblastoma: The same group also reported a case report of a single patient with recurrent multifocal glioblastoma who received multiple local infusions of CAR-T cells targeting IL13Ra2, concluding that administration into the resected cavity controlled local relapse and progression of glioblastoma even in non-injection sites.133